This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Katrin Gröbke Zbinden: Innovator in Factor Xa Inhibitors
Introduction
Katrin Gröbke Zbinden is a notable inventor based in Liestal, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that inhibit coagulation factors.
Latest Patents
Katrin holds a patent for Factor Xa inhibitors, which are novel cycloalkane carboxamides. These compounds are designed to inhibit the coagulation factor Xa and can be utilized as medicaments. The patent details the specific formula (I) and includes physiologically acceptable salts of these compounds.
Career Highlights
Katrin is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. Her work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Katrin has collaborated with esteemed colleagues such as Wolfgang Haap and Hans Hilpert, enhancing her research and development efforts in the field.
Conclusion
Katrin Gröbke Zbinden's work in developing Factor Xa inhibitors showcases her dedication to advancing medical science. Her contributions are vital in the ongoing quest for effective treatments in coagulation disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile